VBLT Overview
Upcoming Projects (VBLT)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (VBLT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (VBLT)
-
Phase 3 event-driven interim analysis of VB-111 for recurrent glioblastoma, or rGBM expected sometime in mid-2017
Ticker: VBLT
Occurred on: May 11, 2017 -
VBLT Announces Complete Phase 2 Results Evaluating VB-111 in Advanced Differentiated Thyroid Cancer
Ticker: VBLT
Occurred on: Feb 21, 2017 -
VBL Therapeutics (VBLT) Announces Overall Survival Data for VB-111 Monotherapy in Phase 2 Study for Recurrent Thyroid Cancer
Ticker: VBLT
Occurred on: Nov 29, 2016 -
VB-111 Clinical Data Presented at ASCO Demonstrate Significant Increase in Overall Survival in Platinum-Resistant Ovarian Cancer
Ticker: VBLT
Occurred on: Jun 06, 2016
Strategic Initiatives (VBLT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
